A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
Clinical trial NCT03170609 · COMPLETED
Trial details
- NCT number
- NCT03170609
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-05
- Primary completion
- 2018-06-25
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.